Znaczenie kwasu dokozaheksaenowego (DHA) w prewencji zaburzeń funkcji poznawczych u osób starszych
References
- Abubakari A.R., Naderali M.M., Naderali E.K.: Omega-3 fatty acid supplementation and cognitive function: Are smaller dosages more beneficial? Int. J. Gen. Med., 2014; 7: 463–473
- AbuMweis S., Jew S., Tayyem R., Agraib L.: Eicosapentaenoic acid and docosahexaenoic acid containing supplements modulate risk factors for cardiovascular disease: A meta-analysis of randomised placebo-control human clinical trials. J. Hum. Nutr. Diet., 2018; 31: 67–84
- Aizawa K., Ageyama N., Yokoyama C., Hisatsune T.: Age-dependent alteration in hippocampal neurogenesis correlates with learning performance of macaque monkeys. Exp. Anim., 2009; 58: 403–407
- Albanese E., Dangour A.D., Uauy R., Acosta D., Guerra M., Guerra S.S., Huang Y., Jacob K.S., de Rodriguez J.L., Noriega L.H., Salas A., Sosa A.L., Sousa R.M., Williams J., Ferri C.P., Prince M.J.: Dietary fish and meat intake and dementia in Latin America, China, and India: A 10/66 Dementia Research Group population-based study. Am. J. Clin. Nutr., 2009; 90: 392–400
- Alexander D.D., Miller P.E., Van Elswyk M.E., Kuratko C.N., Bylsma L.C.: A meta-analysis of randomized controlled trials and prospective cohort studies of eicosapentaenoic and docosahexaenoic long-chain omega-3 fatty acids and coronary heart disease risk. Mayo Clin. Proc., 2017; 92: 15–29
- Ammann E.M., Pottala J.V., Robinson J.G., Espeland M.A., Harris W.S.: Erythrocyte omega-3 fatty acids are inversely associated with incident dementia: Secondary analyses of longitudinal data from the Women’s Health Initiative Memory Study (WHIMS). Prostaglandins Leukot. Essent. Fatty Acids, 2017; 121: 68–75
- Ansari Z.: Homocysteine and mild cognitive impairment: Are these the tools for early intervention in the dementia spectrum? J. Nutr. Health Aging, 2016; 20: 155–160
- Balachandar R., Soundararajan S., Bagepally B.S.: Docosahexaenoic acid supplementation in age-related cognitive decline: A systematic review and meta-analysis. Eur. J. Clin. Pharmacol., 2020; 76: 639–648
- Bannenberg G., Serhan C.N.: Specialized pro-resolving lipid mediators in the inflammatory response: An update. Biochim. Biophys. Acta, 2010; 1801: 1260–1273
- Bayat P.D., Ghanbari A., Moradi M., Raoofi A.: The effects of age and sex on brain volume. Int. J. Morphol., 2014; 32: 1477–1483
- Bazan N.G., Molina M.F., Gordon W.C.: Docosahexaenoic acid signalolipidomics in nutrition: Significance in aging, neuroinflammation, macular degeneration, Alzheimer’s, and other neurodegenerative diseases. Annu. Rev. Nutr., 2011; 31: 321–351
- Bendlin B.B., Fitzgerald M.E., Ries M.L., Xu G., Kastman E.K., Thiel B.W., Rowley H.A., Lazar M., Alexander A.L., Johnson S.C.: White matter in aging and cognition: A cross-sectional study of microstructure in adults aged eighteen to eighty-three. Dev. Neuropsychol., 2010; 35: 257–277
- Bennett I.J., Madden D.J.: Disconnected aging: Cerebral white matter integrity and age-related differences in cognition. Neuroscience, 2014; 276: 187–205
- Bettcher B.M., Kramer J.H.: Inflammation and clinical presentation in neurodegenerative disease: A volatile relationship. Neurocase, 2013; 19: 182–200
- Beydoun M.A., Kaufman J.S., Satia J.A., Rosamond W., Folsom A.R.: Plasma n-3 fatty acids and the risk of cognitive decline in older adults: The atherosclerosis risk in communities study. Am. J. Clin. Nutr., 2007; 85: 1103–1111
- Biagi E., Nylund L., Candela M., Ostan R., Bucci L., Pini E., Nikkïla J., Monti D., Satokari R., Franceschi C., Brigidi P., De Vos W.: Through ageing, and beyond: Gut microbiota and inflammatory status in seniors and centenarians. PLoS One, 2010; 5: e10667
- Boneva N.B., Yamashima T.: New insights into “GPR40-CREB interaction in adult neurogenesis” specific for primates. Hippocampus, 2012; 22: 896–905
- Cai L., Chan J.S., Yan J.H., Peng K.: Brain plasticity and motor practice in cognitive aging. Front. Aging. Neurosci., 2014; 6: 31
- Calder P.C.: n-3 fatty acids, inflammation and immunity: new mechanisms to explain old actions. Proc. Nutr. Soc., 2013; 72: 326–336
- Calder P.C.: Omega-3 fatty acids and inflammatory processes: From molecules to man. Biochem. Soc. Trans., 2017; 45: 1105–1115
- Cannon J.A., Moffitt P., Perez-Moreno A.C., Walters M.R., Broomfield N.M., McMurray J.J., Quinn T.J.: Cognitive impairment and heart failure: Systematic review and meta-analysis. J. Card. Fail., 2017; 23: 464–475
- Cao D., Kevala K., Kim J., Moon H.S., Jun S.B., Lovinger D., Kim H.Y.: Docosahexaenoic acid promotes hippocampal neuronal development and synaptic function. J. Neurochem., 2009; 111: 510–521
- Cherubini A., Andres-Lacueva C., Martin A., Lauretani F., Iorio A.D., Bartali B., Corsi A., Bandinelli S., Mattson M.P., Ferrucci L.: Low plasma N-3 fatty acids and dementia in older persons: The InCHIANTI study. J. Gerontol. A Biol. Sci. Med. Sci., 2007; 62: 1120–1126
- Chhetri J.K., de Souto Barreto P., Soriano G., Gennero I., Cantet C., Vellas B.: Vitamin D, homocysteine and n-3PUFA status according to physical and cognitive functions in older adults with subjective memory complaint: Results from cross-sectional study of the MAPT trial. Exp. Gerontol., 2018; 111: 71–77
- Chin A.V., Robinson D.J., O’Connell H., Hamilton F., Bruce I., Coen R., Walsh B., Coakley D., Molloy A., Scott J., Lawlor B.A., Cunningham C.J.: Vascular biomarkers of cognitive performance in a community-based elderly population: The Dublin Healthy Ageing study. Age Ageing, 2008; 37: 559–564
- Chouinard-Watkins R., Rioux-Perreault C., Fortier M., Tremblay-Mercier J., Zhang Y., Lawrence P., Vohl M.C., Perron P., Lorrain D., Brenna J.T., Cunnane S.C., Plourde M.: Disturbance in uniformly 13C-labelled DHA metabolism in elderly human subjects carrying the apoE ε4 allele. Br. J. Nutr., 2013; 110: 1751–1759
- Ciappolino V., Mazzocchi A., Botturi A., Turolo S., Delvecchio G., Agostoni C., Brambilla P.: The role of docosahexaenoic acid (DHA) on cognitive functions in psychiatric disorders. Nutrients, 2019; 11: 769
- Cipollina C., Salvatore S.R., Muldoon M.F., Freeman B.A., Schopfer F.J.: Generation and dietary modulation of anti-inflammatory electrophilic omega-3 fatty acid derivatives. PLoS One, 2014; 9: e94836
- Colin J., Gregory-Pauron L., Lanhers M.C., Claudepierre T., Corbier C., Yen F.T., Malaplate-Armand C., Oster T.: Membrane raft domains and remodeling in aging brain. Biochimie, 2016; 130: 178–187
- Conklin S.M., Gianaros P.J., Brown S.M., Yao J.K., Hariri A.R., Manuck S.B., Muldoon M.F.: Long-chain omega-3 fatty acid intake is associated positively with corticolimbic gray matter volume in healthy adults. Neurosci. Lett., 2007; 421: 209–212
- Cunnane S.C., Schneider J.A., Tangney C., Tremblay-Mercier J., Fortier M., Bennett D.A., Morris M.C.: Plasma and brain fatty acid profiles in mild cognitive impairment and Alzheimer’s disease. J. Alzheimers Dis., 2012; 29: 691–697
- Daiello L.A., Gongvatana A., Dunsiger S., Cohen R.A., Ott B.R., Alzheimer’s Disease Neuroimaging Initiative: Association of fish oil supplement use with preservation of brain volume and cognitive function. Alzheimers Dement., 2015; 11: 226–235
- Dangour A.D., Allen E., Elbourne D., Fletcher A., Richards M., Uauy R.: Fish consumption and cognitive function among older people in the UK: Baseline data from the OPAL study. J. Nutr. Health Aging, 2009; 13: 198–202
- de Oliveira Otto M.C., Wu J.H., Thacker E.L., Lai H., Lemaitre R.N., McKnight B., Padhye N., Song X., King I.B., Lopez O., Siscovick D., Mozaffarian D.: Longitudinal associations of omega-6 and omega-3 plasma phospholipid polyunsaturated fatty acids with dementia in older adults: The cardiovascular health study. Circulation, 2019; 139: A046
- Dullemeijer C., Durga J., Brouwer I.A., van de Rest O., Kok F.J., Brummer R.J., van Boxtel M.P., Verhoef P.: n3 fatty acid proportions in plasma and cognitive performance in older adults. Am. J. Clin. Nutr., 2007; 86: 1479–1485
- Dyall S.C., Michael G.J., Michael-Titus A.T.: Omega-3 fatty acids reverse age-related decreases in nuclear receptors and increase neurogenesis in old rats. J. Neurosci. Res., 2010; 88: 2091–2102
- Ehninger D., Kempermann G.: Neurogenesis in the adult hippocampus. Cell Tissue Res., 2008; 331: 243–250
- Fairbairn P., Tsofliou F., Johnson A., Dyall S.C.: Effects of a high-DHA multi-nutrient supplement and exercise on mobility and cognition in older women (MOBILE): A randomised semi-blinded placebo-controlled study. Br. J. Nutr., 2020; 124: 146–155
- Faraco G., Brea D., Garcia-Bonilla L., Wang G., Racchumi G., Chang H., Buendia I., Santisteban M.M., Segarra S.G., Koizumi K., Sugiyama Y., Murphy M., Voss H., Anrather J., Iadecola C.: Dietary salt promotes neurovascular and cognitive dysfunction through a gut-initiated TH17 response. Nat. Neurosci., 2018; 21: 240–249
- Fleischman D.A., Leurgans S., Arfanakis K., Arvanitakis Z., Barnes L.L., Boyle P.A., Han S.D., Bennett D.A.: Gray-matter macrostructure in cognitively healthy older persons: Associations with age and cognition. Brain Struct. Funct., 2014; 219: 2029–2049
- Fonteh A.N., Cipolla M., Chiang A.J., Edminster S.P., Arakaki X., Harrington M.G.: Polyunsaturated fatty acid composition of cerebrospinal fluid fractions shows their contribution to cognitive resilience of a pre-symptomatic Alzheimer’s disease cohort. Front. Physiol., 2020; 11: 83
- Goh J.O.: Functional dedifferentiation and altered connectivity in older adults: Neural accounts of cognitive aging. Aging Dis., 2011; 2: 30–48
- Gorelick P.B.: Role of inflammation in cognitive impairment: Results of observational epidemiological studies and clinical trials. Ann. N. Y. Acad. Sci., 2010; 1207: 155–162
- Grande G., Qiu C., Fratiglioni L.: Prevention of dementia in an ageing world: Evidence and biological rationale. Ageing Res. Rev., 2020; 64: 101045
- Green K.N., Martinez-Coria H., Khashwji H., Hall E.B., Yurko-Mauro K.A., Ellis L., LaFerla F.M.: Dietary docosahexaenoic acid and docosapentaenoic acid ameliorate amyloid-β and tau pathology via a mechanism involving presenilin 1 levels. J. Neurosci., 2007; 27: 4385–4395
- Grimm M.O., Kuchenbecker J., Grösgen S., Burg V.K., Hundsdörfer B., Rothhaar T.L., Friess P., de Wilde M.C., Broersen L.M., Penke B., Péter M., Vígh L., Grimm H.S., Hartmann T.: Docosahexaenoic acid reduces amyloid β production via multiple pleiotropic mechanisms. J. Biol. Chem., 2011; 286: 14028–14039
- Groeger A.L., Cipollina C., Cole M.P., Woodcock S.R., Bonacci G., Rudolph T.K., Rudolph V., Freeman B.A., Schopfer F.J.: Cyclooxygenase-2 generates anti-inflammatory mediators from omega-3 fatty acids. Nat. Chem. Biol., 2010; 6: 433–441
- Gu Y., Schupf N., Cosentino S.A., Luchsinger J.A., Scarmeas N.: Nutrient intake and plasma β-amyloid. Neurology, 2012; 78: 1832–1840
- Hafkemeijer A., Altmann-Schneider I., de Craen A.J., Slagboom P.E., van der Grond J., Rombouts S.A.: Associations between age and gray matter volume in anatomical brain networks in middle-aged to older adults. Aging Cell, 2014; 13: 1068–1074
- Haller S., Montandon M.L., Rodriguez C., Garibotto V., Lilja J., Herrmann F.R., Giannakopoulos P.: Amyloid load, hippocampal volume loss, and diffusion tensor imaging changes in early phases of brain aging. Front. Neurosci., 2019; 13: 1228
- Harrison S.L., de Craen A.J., Kerse N., Teh R., Granic A., Davies K., Wesnes K.A., den Elzen W.P., Gussekloo J., Kirkwood T.B., Robinson L., Jagger C., Siervo M., Stephan B.C.: Predicting risk of cognitive decline in very old adults using three models: The Framingham Stroke risk profile; the cardiovascular risk factors, aging, and dementia model; and oxi-inflammatory biomarkers. J. Am. Geriatr. Soc., 2017; 65: 381–389
- Harrison S.L., Ding J., Tang E.Y., Siervo M., Robinson L., Jagger C., Stephan B.C.: Cardiovascular disease risk models and longitudinal changes in cognition: A systematic review. PLoS One, 2014; 9: e114431
- He C., Qu X., Cui L., Wang J., Kang J.X.: Improved spatial learning performance of fat-1 mice is associated with enhanced neurogenesis and neuritogenesis by docosahexaenoic acid. Proc. Natl. Acad. Sci. USA, 2009; 106: 11370–11375
- Hinterberger M., Fischer P.: Folate and Alzheimer: When time matters. J. Neural. Transm., 2013; 120: 211–224
- Hjorth E., Zhu M., Toro V.C., Vedin I., Palmblad J., Cederholm T., Freund-Levi Y., Faxen-Irving G., Wahlund L.O., Basun H., Eriksdotter M., Schultzberg M.: Omega-3 fatty acids enhance phagocytosis of Alzheimer’s disease-related amyloid-β42 by human microglia and decrease inflammatory markers. J. Alzheimers Dis., 2013; 35: 697–713
- Holtzman D.M., Morris J.C., Goate A.M.: Alzheimer’s disease: The challenge of the second century. Sci. Transl. Med., 2011; 3: 77sr1
- Hooijmans C.R., Pasker-de Jong P.C., de Vries R.B., Ritskes-Hoitinga M.: The effects of long-term omega-3 fatty acid supplementation on cognition and Alzheimer’s pathology in animal models of Alzheimer’s disease: A systematic review and meta-analysis. J. Alzheimers Dis., 2012; 28: 191–209
- Howe P.R., Evans H.M., Kuszewski J.C., Wong R.H.: Effects of long chain omega-3 polyunsaturated fatty acids on brain function in mildly hypertensive older adults. Nutrients, 2018; 10: 1413
- Huang T., Wahlqvist M.L., Li D.: Effect of n-3 polyunsaturated fatty acid on gene expression of the critical enzymes involved in homocysteine metabolism. Nutr. J., 2012; 11: 6
- Huang T., Zheng J., Chen Y., Yang B., Wahlqvist M.L., Li D.: High consumption of Ω-3 polyunsaturated fatty acids decrease plasma homocysteine: A meta-analysis of randomized, placebo-controlled trials. Nutrition, 2011; 27: 863–867
- Jiao J., Li Q., Chu J., Zeng W., Yang M., Zhu S.: Effect of n-3 PUFA supplementation on cognitive function throughout the life span from infancy to old age: A systematic review and meta-analysis of randomized controlled trials. Am. J. Clin. Nutr., 2014; 100: 1422–1436
- Kawakita E., Hashimoto M., Shido O.: Docosahexaenoic acid promotes neurogenesis in vitro and in vivo. Neuroscience, 2006; 139: 991–997
- Kempermann G., Gage F.H., Aigner L., Song H., Curtis M.A., Thuret S., Kuhn H.G., Jessberger S., Frankland P.W., Cameron H.A., Gould E., Hen R., Abrous D.N., Toni N., Schinder A.F. i wsp.: Human adult neurogenesis: Evidence and remaining questions. Cell Stem Cell, 2018; 23: 25–30
- Kim H.L., Kim D.K., Kang S.W., Park Y.K.: Association of nutrient intakes with cognitive function in Koreans aged 50 years and older. Clin. Nutr. Res., 2018; 7: 199–212
- Kim J., Park M.H., Kim E., Han C., Jo S.A., Jo I.: Plasma homocysteine is associated with the risk of mild cognitive impairment in an elderly Korean population. J. Nutr., 2007; 137: 2093–2097
- Klempin F., Kempermann G.: Adult hippocampal neurogenesis and aging. Eur. Arch. Psychiatry Clin. Neurosci., 2007; 257: 271–280
- Kolan M.: Zaburzenia funkcji poznawczych a choroby niedokrwienne mózgu. W: Neurokognitywistyka w patologii i zdrowiu 2009–2011, red.: I. Kojder. Wydawnictwo Pomorskiego Uniwersytetu Medycznego, Szczecin 2011, 94–105
- Kotwal S., Jun M., Sullivan D., Perkovic V., Neal B.: Omega 3 fatty acids and cardiovascular outcomes: Systematic review and meta-analysis. Circ. Cardiovasc. Qual. Outcomes, 2012; 5: 808–818
- Kröger E., Verreault R., Carmichael P.H., Lindsay J., Julien P., Dewailly E., Ayotte P., Laurin D.: Omega-3 fatty acids and risk of dementia: The Canadian study of health and aging. Am. J. Clin. Nutr., 2009; 90: 184–192
- Kume A., Kurotani K., Sato M., Ejima Y., Pham N.M., Nanri A., Kuwahara K., Mizoue T.: Polyunsaturated fatty acids in serum and homocysteine concentrations in Japanese men and women: A cross-sectional study. Nutr. Metab., 2013; 10: 41
- Ledesma M.D., Martin M.G., Dotti C.G.: Lipid changes in the aged brain: Effect on synaptic function and neuronal survival. Prog. Lipid. Res., 2012; 51: 23–35
- Lopez L.B., Kritz-Silverstein D., Barrett Connor E.: High dietary and plasma levels of the omega-3 fatty acid docosahexaenoic acid are associated with decreased dementia risk: The Rancho Bernardo study. J. Nutr. Health Aging, 2011; 15: 25–31
- Lord S.R., Delbaere K., Sturnieks D.L.: Chapter 10 – Aging. W: Handbook of Clinical Neurology, Volume 159, red.: B.L. Day, S.R. Lord. Elsevier, 2018, 157–171
- Lu Z.H., Li J., Li X.L., Ding M., Mao C.J., Zhu X.Y., Liu C.F.: Hypertension with hyperhomocysteinemia increases the risk of early cognitive impairment after first-ever ischemic stroke. Eur. Neurol., 2019; 82: 75–85
- Ma F., Zhou X., Li Q., Zhao J., Song A., An P., Du Y., Xu W., Huang G.: Effects of folic acid and vitamin B12, alone and in combination on cognitive function and inflammatory factors in the elderly with mild cognitive impairment: A single-blind experimental design. Curr. Alzheimer Res., 2019; 16: 622–632
- Manders M., Vasse E., de Groot L.C., van Staveren W.A., Bindels J.G., Blom H.J., Hoefnagels W.H.: Homocysteine and cognitive function in institutionalised elderly A cross-sectional analysis. Eur. J. Nutr., 2006; 45: 70–78
- Marciniak-Łukasik K.: Rola i znaczenie kwasów tłuszczowych omega-3. Żywn. Nauka Technol. Jakość, 2011; 18: 24–35
- McNamara R.K., Kalt W., Shidler M.D., McDonald J., Summer S.S., Stein A.L., Stover A.N., Krikorian R.: Cognitive response to fish oil, blueberry, and combined supplementation in older adults with subjective cognitive impairment. Neurobiol. Aging, 2018; 64: 147–156
- Middleton L.E., Yaffe K.: Promising strategies for the prevention of dementia. Arch. Neurol., 2009; 66: 1210–1215
- Mora F., Segovia G., del Arco A.: Aging, plasticity and environmental enrichment: Structural changes and neurotransmitter dynamics in several areas of the brain. Brain Res. Rev., 2007; 55: 78–88
- Noble J.M., Manly J.J., Schupf N., Tang M.X., Mayeux R., Luchsinger J.A.: Association of C-reactive protein with cognitive impairment. Arch. Neurol., 2010; 67: 87–92
- Nyberg L., Lövdén M., Riklund K., Lindenberger U., Bäckman L.: Memory aging and brain maintenance. Trends Cogn. Sci., 2012; 16: 292–305
- Otsuka R., Tange C., Nishita Y., Kato Y., Imai T., Ando F., Shimokata H.: Serum docosahexaenoic and eicosapentaenoic acid and risk of cognitive decline over 10 years among elderly Japanese. Eur. J. Clin. Nutr., 2014; 68: 503–509
- Park D.C., Reuter-Lorenz P.: The adaptive brain: Aging and neurocognitive scaffolding. Annu. Rev. Psychol., 2009; 60: 173–196
- Peng H.Y., Man C.F., Xu J., Fan Y.: Elevated homocysteine levels and risk of cardiovascular and all-cause mortality: A meta-analysis of prospective studies. J. Zhejiang Univ. Sci. B, 2015; 16: 78–86
- Pobrotyn P., Susło R., Witczak I.T., Rypicz L., Drobnik J.: An analysis of the costs of treating aged patients in a large clinical hospital in Poland under the pressure of recent demographic trends. Arch. Med. Sci., 2020; 16: 666–671
- Qin B., Plassman B.L., Edwards L.J., Popkin B.M., Adair L.S., Mendez M.A.: Fish intake is associated with slower cognitive decline in Chinese older adults. J. Nutr., 2014; 144: 1579–1585
- Raji C.A., Erickson K.I., Lopez O.L., Kuller L.H., Gach H.M., Thompson P.M., Riverol M., Becker J.T.: Regular fish consumption and age-related brain gray matter loss. Am. J. Prev. Med., 2014; 47: 444–451
- Rao J.S., Ertley R.N., Lee H.J., DeMar J.C. Jr., Arnold J.T., Rapoport S.I., Bazinet R.P.: n-3 polyunsaturated fatty acid deprivation in rats decreases frontal cortex BDNF via a p38 MAPK-dependent mechanism. Mol. Psychiatry, 2007; 12: 36–46
- Reitz C., Tang M.X., Miller J., Green R., Luchsinger J.A.: Plasma homocysteine and risk of mild cognitive impairment. Dement. Geriatr. Cogn. Disord., 2009; 27: 11–17
- Roberts R.O., Geda Y.E., Knopman D.S., Boeve B.F., Christianson T.J., Pankratz V.S., Kullo I.J., Tangalos E.G., Ivnik R.J., Petersen R.C.: Association of C-reactive protein with mild cognitive impairment. Alzheimers Dement., 2009; 5: 398–405
- Robson L.G., Dyall S., Sidloff D., Michael-Titus A.T.: Omega-3 polyunsaturated fatty acids increase the neurite outgrowth of rat sensory neurones throughout development and in aged animals. Neurobiol. Aging, 2010; 31: 678–687
- Sachdev P.S., Blacker D., Blazer D.G., Ganguli M., Jeste D.V., Paulsen J.S., Petersen R.C.: Classifying neurocognitive disorders: The DSM-5 approach. Nat. Rev. Neurol., 2014; 10: 634–642
- Samieri C., Lorrain S., Buaud B., Vaysse C., Berr C., Peuchant E., Cunnane S.C., Barberger-Gateau P.: Relationship between diet and plasma long-chain n-3 PUFAs in older people: Impact of apolipoprotein E genotype. J. Lipid. Res., 2013; 54: 2559–2567
- Santangeli P., Di Biase L., Bai R., Mohanty S., Pump A., Cereceda Brantes M., Horton R., Burkhardt J.D., Lakkireddy D., Reddy Y.M., Casella M., Dello Russo A., Tondo C., Natale A.: Atrial fibrillation and the risk of incident dementia: A meta-analysis. Heart Rhythm, 2012; 9: 1761–1768
- Schaefer E.J., Bongard V., Beiser A.S., Lamon-Fava S., Robins S.J., Au R., Tucker K.L., Kyle D.J., Wilson P.W., Wolf P.A.: Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: The Framing-ham Heart Study. Arch. Neurol., 2006; 63: 1545–1550
- Serhan C.N., Dalli J., Colas R.A., Winkler J.W., Chiang N.: Protectins and maresins: New pro-resolving families of mediators in acute inflammation and resolution bioactive metabolome. Biochim. Biophys. Acta, 2015; 1851: 397–413
- Serini S., Bizzarro A., Piccioni E., Fasano E., Rossi C., Lauria A., Cittadini A.R., Masullo C., Calviello G.: EPA and DHA differentially affect in vitro inflammatory cytokine release by peripheral blood mononuclear cells from Alzheimer’s patients. Curr. Alzheimer Res., 2012; 9: 913–923
- Stephan B.C.M., Harrison S.L., Keage H.A.D., Babateen A., Robinson L., Siervo M.: Cardiovascular disease, the nitric oxide pathway and risk of cognitive impairment and dementia. Curr. Cardiol. Rep., 2017; 19: 87
- Stillwell W., Shaikh S.R., Zerouga M., Siddiqui R., Wassall S.R.: Docosahexaenoic acid affects cell signaling by altering lipid rafts. Reprod. Nutr. Dev., 2005; 45: 559–579
- Sun G.Y., Simonyi A., Fritsche K.L., Chuang D.Y., Hannink M., Gu Z., Greenlief C.M., Yao J.K., Lee J.C., Beversdorf D.Q.: Docosahexaenoic acid (DHA): An essential nutrient and a nutraceutical for brain health and diseases. Prostaglandins Leukot. Essent. Fatty Acids, 2018; 136: 3–13
- Szponar L., Mojska H., Ołtarzewski Ł., Piotrowska K.: Tłuszcze. W: Normy żywienia dla populacji Polski, red.: M. Jarosz. Instytut Żywności i Żywienia, Warszawa 2017, 56–75
- Szwed A., Miłowska K.: Rola białek w chorobach neurodegeneracyjnych. Postępy Hig. Med. Dośw., 2012; 66: 187–195
- Takao H., Hayashi N., Ohtomo K.: A longitudinal study of brain volume changes in normal aging. Eur. J. Radiol., 2012; 81: 2801–2804
- Tan J.H., Abdin E., Shahwan S., Zhang Y., Sambasivam R., Vaingankar J.A., Mahendran R., Chua H.C., Chong S.A., Subramaniam M.: Happiness and cognitive impairment among older adults: Investigating the mediational roles of disability, depression, social contact frequency, and loneliness. Int. J. Environ. Res. Public Health, 2019; 16: 4954
- Tan Z.S., Harris W.S., Beiser A.S., Au R., Himali J.J., Debette S., Pikula A., Decarli C., Wolf P.A., Vasan R.S., Robins S.J., Seshadri S.: Red blood cell ω-3 fatty acid levels and markers of accelerated brain aging. Neurology, 2012; 78: 658–664
- Titova O.E., Sjögren P., Brooks S.J., Kullberg J., Ax E., Kilander L., Riserus U., Cederholm T., Larsson E.M., Johansson L., Ahlström H., Lind L., Schiöth H.B., Benedict C.: Dietary intake of eicosapentaenoic and docosahexaenoic acids is linked to gray matter volume and cognitive function in elderly. Age, 2013; 35: 1495–1505
- Treder N., Jodzio K.: Heterogeniczność funkcjonowania poznawczego i jego zaburzeń u osób star-szych. Psychiatria i Psychoterapia, 2013; 9: 3–13
- van de Rest O., Spiro A. 3rd, Krall-Kaye E., Geleijnse J.M., de Groot L.C., Tucker K.L.: Intakes of (n-3) fatty acids and fatty fish are not associated with cognitive performance and 6-year cognitive change in men participating in the Veterans Affairs Normative Aging Study. J. Nutr., 2009; 139: 2329–2336
- van Gelder B.M., Tijhuis M., Kalmijn S., Kromhout D.: Fish consumption, n-3 fatty acids, and subsequent 5-y cognitive decline in elderly men: The Zutphen Elderly Study. Am. J. Clin. Nutr., 2007; 85: 1142–1147
- Vedin I., Cederholm T., Freund Levi Y., Basun H., Garlind A., Faxén Irving G., Jönhagen M.E., Vessby B., Wahlund L.O., Palmblad J.: Effects of docosahexaenoic acid-rich n-3 fatty acid supplementation on cytokine release from blood mononuclear leukocytes: The OmegAD study. Am. J. Clin. Nutr., 2008; 87: 1616–1622
- Vela S., Sainz N., Moreno-Aliaga M.J., Solas M., Ramirez M.J.: DHA selectively protects SAMP-8-associated cognitive deficits through inhibition of JNK. Mol. Neurobiol., 2019; 56: 1618–1627
- Virtanen J.K., Siscovick D.S., Lemaitre R.N., Longstreth W.T., Spiegelman D., Rimm E.B., King I.B., Mozaffarian D.: Circulating omega-3 polyunsaturated fatty acids and subclinical brain abnormalities on MRI in older adults: The Cardiovascular Health Study. J. Am. Heart Assoc., 2013; 2: e000305
- Vogels R.L., Scheltens P., Schroeder-Tanka J.M., Weinstein H.C.: Cognitive impairment in heart failure: A systematic review of the literature. Eur. J. Heart Fail., 2007; 9: 440–449
- Wandell B.A.: Clarifying human white matter. Annu. Rev. Neurosci., 2016; 39: 103–128
- Weiser M.J., Butt C.M., Mohajeri M.H.: Docosahexaenoic acid and cognition throughout the lifespan. Nutrients, 2016; 8: 99
- Wróblewska I., Zborowska I., Dąbek A., Susło R., Wróblewska Z., Drobnik J.: Health status, health behaviors, and the ability to perform everyday activities in Poles aged ≥65 years staying in their home environment. Clin. Interv. Aging, 2018; 13: 355–363
- Wu A., Ying Z., Gomez-Pinilla F.: Docosahexaenoic acid dietary supplementation enhances the effects of exercise on synaptic plasticity and cognition. Neuroscience, 2008; 155: 751–759
- Wu S., Ding Y., Wu F., Li R., Hou J., Mao P.: Omega-3 fatty acids intake and risks of dementia and Alzheimer’s disease: A meta-analysis. Neurosci. Biobehav. Rev., 2015; 48: 1–9
- Yassine H.N., Rawat V., Mack W.J., Quinn J.F., Yurko-Mauro K., Bailey-Hall E., Aisen P.S., Chui H.C., Schneider L.S.: The effect of APOE genotype on the delivery of DHA to cerebrospinal fluid in Alzheimer’s disease. Alzheimers Res. Ther., 2016; 8: 25
- Yurko-Mauro K., Alexander D.D., Van Elswyk M.E.: Docosahexaenoic acid and adult memory: A systematic review and meta-analysis. PLoS One, 2015; 10: e0120391
- Zhang Y., Chen J., Qiu J., Li Y., Wang J., Jiao J.: Intakes of fish and polyunsaturated fatty acids and mild-to-severe cognitive impairment risks: A dose-response meta-analysis of 21 cohort studies. Am. J. Clin. Nutr., 2016; 103: 330–340
DOI: https://doi.org/10.5604/01.3001.0014.8986 | Journal eISSN: 1732-2693
Language: English
Page range: 345 - 361
Submitted on: Jan 8, 2020
Accepted on: Sep 11, 2020
Published on: May 25, 2021
Published by: Hirszfeld Institute of Immunology and Experimental Therapy
In partnership with: Paradigm Publishing Services
Publication frequency: 1 times per year
Related subjects:
© 2021 Agata Białecka-Dębek, Dominika Granda, Barbara Pietruszka, published by Hirszfeld Institute of Immunology and Experimental Therapy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.